Embedded Files
The Center for Prostate Disease Research (CPDR) 2nd Annual Scientific Retreat took place April 17, 2025, in the HJF Conference Center and included 150 participants. The event featured 10 distinguished speakers, including national leaders in prostate cancer research, and four young scientists from Johns Hopkins University and CPDR.
The highlight was the Keynote Address by Dr. Isla Garraway, from the University of California Los Angeles David Geffen School of Medicine and the VA Healthcare System, with her presentation titled “The VA Multi-OMICS Analysis Platform for Prostate Cancer (VA-MAPP) - Activating a Learning Healthcare System Model to Improve Outcomes for Veterans.”
The agenda featured four sessions covering critical research areas:
Genomics of Prostate Cancer
Tumor Immune Microenvironment
Next Generations Cancer Therapeutics
Advance Molecular Biology of Lethal Prostate Cancer
The retreat concluded with a presentation from Dr. Artie Shelton, veteran and prostate cancer survivor, and an engaging poster session and award ceremony.
Gregory Chesnut, M.D., FACS, CAPT, MC, USN, with CPDR Overview: Prostate Cancer Care in the Equal Access DoD Healthcare System
Isla Garraway, M.D., Ph.D., Keynote Speaker: The VA Multi-OMICS Analysis Platform for Prostate Cancer (VA-MAPP) - Activating a Learning Healthcare System Model to Improve Outcomes for Veterans
Leigh Ellis, Ph.D., CPDR Scientific Director
CPDR Retreat Presenters L-R: Elise DeArment (CPDR), Dr. Beatriz German-Falcon (CPDR), Dr. Irfan Asangani (University of Pennsylvania), Dr. Gail Prins (University of Illinois, Chicago), Dr. Saul Priceman (University of Southern California), Dr. Isla Garraway, Keynote Address (University of California Los Angeles, VA Healthcare System), Dr. James Gulley (National Cancer Institute, National Institutes of Health), Dr. Clayton Yates (Johns Hopkins University), Dr. Gregory Chesnut (CPDR), Dr. Christopher Barbieri (Weill Cornell Medicine), Dr. Qianban Wang, Duke University School of Medicine), Dr. Massimo Loda (Weill Cornell Medicine).
CPDR Director Dr. Gregory Chesnut and Artie Shelton, M.D. COL(Ret.), Prostate Cancer Survivor Presenter, Prostate Health Education Network, INC (PHEN)
500+ scientific articles have been published in the past 32 years
259K biospecimen units collected from 800+ patients
31K military patients with prostate cancer data, integrated with 5 DoD and 1 civilian medical centers in Multicenter National Database Study
CPDR Groundbreaking Discoveries
CPDR Groundbreaking Discoveries
Developed and validated emerging diagnostic, prognostic, and therapeutic approaches through a long term (since 1993) bio-molecular specimen bank (230,000 units from 7000+ patients), e.g., ERG oncoprotein-based stratification of prostate cancer (PMID: 22331093) and Oncotype DX Prostate Cancer test (PMID: 25465337, PMID: 26723180).
CPDR WRNMMC
CPDR WRNMMC
Walter Reed National Military Medical Center
Building 19, 3rd Floor
4954 North Palmer Rd. Bethesda, MD 20889-5600
Phone: (301) 319-2900
Report abuse